CARGO Therapeutics (CRGX) Reports Q3 Loss of $47.37

CARGO Therapeutics (NASDAQ: CRGX) reported Q3 EPS of ($47.37).

As of September 30, 2023, CARGO had cash and cash equivalents of $60.3 million and approximately $438 million, as adjusted for the net proceeds from the third tranche of the Company’s Series A financing in October and its IPO in November which it expects will fund operations through 2025.

For earnings history and earnings-related data on CARGO Therapeutics (CRGX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus